| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |